Hoth Therapeutics Inc reported a corporate restructuring and rebranding Tuesday that sent its shares lower in premarket trading. The company said it will adopt the name Rocket One, Inc. and reorganize to pursue opportunities in AI infrastructure and semiconductor technologies, and the stock fell 10.9% in premarket trading following the announcement.
As part of the strategic pivot, the company said it has obtained exclusive rights to technologies developed at Virginia Commonwealth University. The licenses cover a nanomagnetic semiconductor approach and a spintronic computing architecture that the company says are targeted at reducing power consumption and improving computing efficiency in AI data centers through ultra-low-power computing designs.
Hoth said it will enter the AI semiconductor market via a newly formed wholly owned subsidiary while continuing to operate its existing biotechnology programs. The company also indicated it will explore placing its biotechnology assets into a separate subsidiary as part of the reorganization.
The company’s Board of Directors unanimously approved the restructuring. Hoth said additional particulars will be disclosed in a Form 8-K filing with the Securities and Exchange Commission.
According to the company, the exclusive rights cover two specific technologies: a nanomagnetic matrix multiplier intended to accelerate AI hardware, and a spintronic memory platform designed for defense, autonomous systems, and space computing applications. The company noted that matrix multiplication is the foundational operation underlying modern AI workloads, including transformer architectures that power large language models.
Rocket One’s stated growth approach will emphasize capital efficiency and include semiconductor infrastructure partnerships, commercialization of AI hardware, sponsored research, selective acquisitions, and opportunities in defense and aerospace.
Robb Knie, Chief Executive Officer, was quoted by the company saying, "We believe next-generation semiconductor architectures capable of dramatically improving power efficiency, memory performance, and intelligent computing scalability represent one of the largest opportunities in global technology today." The company said it intends to broaden its leadership team with expertise across semiconductor operations, AI infrastructure, advanced computing architectures, defense technologies, and high-performance computing.
Summary
Hoth Therapeutics announced a name change to Rocket One and a strategic shift into AI semiconductor technologies via exclusive licenses from Virginia Commonwealth University. The move includes creation of a wholly owned subsidiary focused on AI semiconductors, continued biotechnology programs with potential separation into their own subsidiary, and a capital-efficient growth plan. The Board approved the restructuring unanimously and more details will be provided in a forthcoming Form 8-K. The company’s shares declined 10.9% in premarket trading following the announcement.
Key points
- Hoth Therapeutics will rebrand as Rocket One, Inc. and pursue AI infrastructure and semiconductor opportunities.
- The company secured exclusive rights to a nanomagnetic matrix multiplier and a spintronic memory platform developed at Virginia Commonwealth University.
- Management plans a capital-efficient expansion via partnerships, AI hardware commercialization, sponsored research, strategic acquisitions, and defense and aerospace engagements.
Risks and uncertainties
- Investor reaction: the stock fell 10.9% in premarket trading after the announcement, reflecting immediate market uncertainty about the shift.
- Limited public detail: additional specifics about the restructuring and related transactions will be supplied in a Form 8-K, indicating current information is incomplete.
- Business separation plans: the company said it will explore placing biotechnology assets in a separate subsidiary, an arrangement whose structure and timing remain unspecified.